10 High Growth Dividend Paying Stocks To Invest In

5. Eli Lilly and Company (NYSE:LLY)

5-Year Revenue Growth: 15.08%

Eli Lilly and Company (NYSE:LLY) ranks fifth on our list of the best high growth stocks that pay dividends. The American multinational pharmaceutical company offers a wide range of related services and products to its consumers. The company offers a quarterly dividend of $1.50 per share and has a dividend yield of 0.82%, as of April 8. It holds one of the strongest dividend policies in the market, having paid regular dividends for 139 consecutive years and growing its payouts for 11 years in a row.

A major drug that investors will be watching closely this year is orforglipron, a once-daily oral treatment being developed by Eli Lilly and Company (NYSE:LLY) for weight loss and other health conditions. While early trial data has shown promise, the upcoming results from phase 3 studies—expected in the coming months—will be crucial in determining the drug’s chances of gaining regulatory approval.

Throughout the year, Eli Lilly plans to release data from several phase 3 trials assessing orforglipron’s effectiveness in treating diabetes, obesity, and sleep apnea. The first of these studies is projected to wrap up in April.

In the fourth quarter of 2024, Eli Lilly and Company (NYSE:LLY) reported a significant revenue jump of 45% year-over-year, reaching $13.53 billion, driven by strong demand for Mounjaro and Zepbound. Earnings per share more than doubled, increasing by 102% to $4.88. The company also continued strengthening its product pipeline, gaining U.S. approval for Zepbound as a treatment for moderate-to-severe obstructive sleep apnea in adults with obesity, as well as approval for Omvoh to treat moderately to severely active Crohn’s disease. It is one of the best high growth stocks to buy as the company has grown its revenue by over 15% in the past five years.